4,5-二甲氧基-1H-吲哚-2-甲酸 | 50536-49-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4,5-二甲氧基-1H-吲哚-2-甲酸
• 中文别名: 4,5-二甲氧基-1H-吲哚-2-羧酸
• 英文名称: 4,5-dimethoxy-1H-indole-2-carboxylic acid
• CAS: 50536-49-7
• 化学式: C₁₁H₁₁NO₄
• mdl: MFCD02664472
• 分子量: 221.213
• InChiKey: OJLHCDSLZDJBKE-UHFFFAOYSA-N

物化性质

• 沸点：
  456.2±40.0 °C(Predicted)
• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.181
• 拓扑面积：
  71.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  4,5-二甲氧基-1H-吲哚-2-甲酸 在 喹啉 、 铜 作用下， 以83%的产率得到4,5-二甲氧基-1H-吲哚
  参考文献：
  名称：

  Effects of Indole Fatty Alcohols on the Differentiation of Neural Stem Cell Derived Neurospheres

  摘要：

  In a search for inducers of neuronal differentiation to treat neurodegenerative diseases such as Alzheimer's disease, a series of indole fatty alcohols (IFAs) were prepared. 13C (n = 18) was able to promote the differentiation of neural stem cell derived neurospheres into neurons at a concentration of 10 nM. Analysis of the expression of the Notch pathway genes in neurospheres treated during the differentiation phase with 13c (n = 18) revealed a significant decrease in the transcription of the Notch 4 receptor.

  DOI：

  10.1021/jm0493616
• 作为产物：
  描述：

  2-azido-3-(2',3'-dimethoxyphenyl)acrylic acid methyl ester 在 sodium hydroxide 作用下， 以 xylene 为溶剂， 生成 4,5-二甲氧基-1H-吲哚-2-甲酸
  参考文献：
  名称：

  Effects of Indole Fatty Alcohols on the Differentiation of Neural Stem Cell Derived Neurospheres

  摘要：

  In a search for inducers of neuronal differentiation to treat neurodegenerative diseases such as Alzheimer's disease, a series of indole fatty alcohols (IFAs) were prepared. 13C (n = 18) was able to promote the differentiation of neural stem cell derived neurospheres into neurons at a concentration of 10 nM. Analysis of the expression of the Notch pathway genes in neurospheres treated during the differentiation phase with 13c (n = 18) revealed a significant decrease in the transcription of the Notch 4 receptor.

  DOI：

  10.1021/jm0493616

文献信息

• [EN] FUSED TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS<br/>[FR] COMPOSÉS PYRIDONES TÉTRACYCLIQUES FUSIONNÉS EN TANT QU'AGENTS ANTIVIRAUX
  申请人：NOVARTIS AG

  公开号：WO2018073753A1

  公开（公告）日：2018-04-26

  The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by hepatitis B virus, and reducing the occurrence of serious conditions associated with HBV.

  该发明提供了如下所述的Formula (I)的化合物，以及药学上可接受的盐、含有这些化合物的药物组合物，以及使用这些化合物、盐和组合物治疗病毒感染的方法，特别是由乙型肝炎病毒引起的感染，并减少与HBV相关的严重病情发生的方法。
• [EN] FAAH INHIBITORS<br/>[FR] INHIBITEURS DE FAAH
  申请人：IRONWOOD PHARMACEUTICALS INC

  公开号：WO2012088469A1

  公开（公告）日：2012-06-28

  The present disclosure relates to compounds useful as inhibitors of the enzyme Fatty Acid Amide Hydrolase (FAAH). The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment or prevention of various disorders. Compounds of the invention are described in Table 1.

  本公开涉及作为脂肪酰胺水解酶（FAAH）抑制剂有用的化合物。该公开还提供包括本公开化合物的药学上可接受的组合物，以及使用这些组合物在治疗或预防各种疾病中的方法。发明的化合物在表1中描述。
• [EN] INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS D'INDOLE CARBOXAMIDE ET LEURS UTILISATIONS
  申请人：NOVARTIS AG

  公开号：WO2014037900A1

  公开（公告）日：2014-03-13

  A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein.

  提供了一种化合物，其化学式为（I），已被证明对治疗通过mmpL3途径中的必需分子的运输介导的疾病、紊乱或综合症具有益处：（I）其中R1、R2、R3、R4、R5和R6如本文所定义。
• INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF
  申请人：Jiricek Jan

  公开号：US20150175539A1

  公开（公告）日：2015-06-25

  A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein.

  提供一种化合物，其化学式为（I），已被证明可用于治疗由mmpL3途径中必需分子的运输介导的疾病、障碍或综合症：其中R1、R2、R3、R4、R5和R6如此定义。
• FAAH Inhibitors
  申请人：Hudson Colleen

  公开号：US20150175599A1

  公开（公告）日：2015-06-25

  The present disclosure relates to compounds useful as inhibitors of the enzyme Fatty Acid Amide Hydrolase (FAAH). The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment or prevention of various disorders. Compounds of the invention are described in Table 1.

  本公开涉及一种作为脂肪酸酰胺水解酶（FAAH）抑制剂有用的化合物。本公开还提供了包含本公开化合物的药学上可接受的组合物，以及使用这些组合物在治疗或预防各种疾病的方法。发明的化合物在表1中描述。